[Application of tranexamic acid within the field of dentistry]. / Die Anwendung von Tranexamsäure (Cyklokapron®) in der Zahnmedizin.
Swiss Dent J
; 131(10): 827-829, 2021 Oct 11.
Article
em De
| MEDLINE
| ID: mdl-34610735
ABSTRACT
The antifibrinolytic agent tranexamic acid (TXA) is well known for its capacity to effectively reduce intraoperative blood loss. The effect mechanism of TXA is based on the indirect inhibition of fibrin degradation, whereby existing blood clots within the surgical area are stabilized. Consecutively, the amount of blood loss can be reduced. Due to its great efficacy to minimize blood loss and its low rate of unintended side effects, TXA is regularly used in different surgical fields. Within the field of dentistry TXA is not applied on a regular basis, however, it presents a highly effective and convenient treatment option to reduce bleeding complications.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Ácido Tranexâmico
/
Antifibrinolíticos
Limite:
Humans
Idioma:
De
Ano de publicação:
2021
Tipo de documento:
Article